Thyroid cancer is increasing in the United States. Surgery is the standard treatment. For some patients, radioactive iodine is also used after surgery to help reduce recurrence of the disease. A new study finds that while use of this therapy is increasing, there is also wide variation in radioactive iodine treatment among hospitals. Catherine Dolf explains in this week’s JAMA Report.